Dexamethasone At-induction vs At-night to Prevent Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Protocol for Randomized Clinical Trial
| Registry | NCT05998317 |
|---|---|
| Status | Completed |
| Phase | Phase 2 / Phase 3 |
| Study type | Interventional; randomized, parallel, masking: triple, prevention |
| Enrollment | 60 (Actual) |
| Sponsor | Mansoura University (Other) |
| Conditions | Postoperative Nausea and Vomiting, Postoperative Pain, Laparoscopic Cholecystectomy |
| Interventions | At-night Dexamethasone, At-induction Dexamethasone (Drug) |
| Dates | start 2023-10-08, primary completion 2023-11-15, completion 2023-11-20, first posted 2023-08-18, last updated 2024-01-25 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Postoperative Nausea and Vomiting All trials for Postoperative Pain All trials of At-night Dexamethasone All trials of At-induction Dexamethasone
Since the peak effect of the dexamethasone is delayed to 12-16 hours after iv administration, we designed this study to investigate the effect of administering dexamethasone at-night before surgery versus at-induction (the standard timing) in prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.
A pilot randomized controlled study (60 cases) will be started to explore the potential difference, ensure correct and rigorous data collection, and calculate the sample size for a larger pragmatic trial.
Background:
Postoperative nausea and vomiting (PONV) are common complications after laparoscopic cholecystectomy. The aim of this study is to evaluate the efficacy of administration of prophylactic dexamethasone 12-hours prior to induction of anesthesia in preventing PONV after elective laparoscopic cholecystectomy, as it reaches its peak effect at 2-12 hours and lasts for 72 hours after intravenous (iv) administration.
Methods:
This is a parallel two-arm, randomized (1:1), double-blind, controlled, single-center trial. Adults (≥18 years) with American Society of Anesthesiology (ASA) physical status I-III scheduled for elective laparoscopic cholecystectomy will be eligible for inclusion. The participants will be randomized to receive either 8 mg IV Dexamethasone at time of induction of anesthesia or 8 mg IV Dexamethasone at 12 hours prior to induction of anesthesia. The primary outcome will be the incidence of postoperative nausea and vomiting. A total of 60 patients will be recruited as a pilot study.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| At-night dexamethasone | Experimental | Drug: At-night Dexamethasone | Patients in the intervention group will receive intravenous 8 mg dexamethasone at night before surgery. The time of dexamethasone administration will be recorded. The dexamethasone ampule will be diluted in a 10 ml syringe and given in at least one minute to avoid unpleasant sensation in injection. |
| At-induction dexamethasone | Active comparator | Drug: At-induction Dexamethasone | Patients in the control group will receive intravenous 8 mg dexamethasone just before or at the induction of anesthesia. The dexamethasone ampule will be diluted in a 10 ml syringe and given in at least one minute to avoid unpleasant sensation in injection. |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * all consecutive adults (older than 18 years) with ASA physical status I-III undergoing elective laparoscopic cholecystectomy surgery at gastrointestinal surgery center. Exclusion Criteria: * patient refusal * use of steroids or antiemetic agents within 1 week of surgery * chronic opioid therapy * history of allergy to any study medications * serum creatinine > 1.4 mg/dl * liver enzymes more than triple normal limits * pregnancy * psychiatric or neurologic diseases or socioeconomic status that would hinder postoperative quality of recovery questionnaire * Patients whose laparoscopic surgery is converted to open surgery after enrollment will be excluded.
| Facility | City | Country | Status |
|---|---|---|---|
| Faculty of Medicine | Al Mansurah, Aldakahlia | Egypt |